ArticleBiomolecules & therapeutics2021

SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90.

Bin Lian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.